Portland, Oregon-- (Newsfile Corp. - October 23, 2026) - On October 23, 2026, the board of directors of Portland General ...
Ultragenyx Pharmaceutical (RARE) and Baylor Research Institute have entered into a settlement agreement with Navinta to resolve patent litigation related to Dojolvi oral liquid, a ...
On October 23, 2026, the board of directors of Portland General Electric Company (NYSE: POR) declared a quarterly common stock dividend of $0.55125 ...
The Phase 1 study assesses a zirconium-89 imaging counterpart for safety and tumor uptake; lung models test ATNM-400 alone ...
October 1, 2026) - Portland General Electric (NYSE: POR) today began buying and selling energy through the California Independent System Operator's (CAISO) new Extended Day-Ahead Market (EDAM), ...
NOVATO, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has entered into a definitive agreement to sell a Rare Pediatric Disease ...
Pool Corporation (Nasdaq: POOL) announced today that its Board of Directors (the Board) appointed Jean-Marc Germain to serve as a director upon recommendation of the Nominating and Corporate ...
A reported incident involving a woman identified as Jasmine Arora raises concerns about an alleged WhatsApp message offering ...
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a technology company in defense, national security, and global ...
TEL AVIV, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- TAPI (Technology & API Services) today announced the appointment of Serge Rogasik as its Chief Executive Officer. Mr. Rogasik will lead a global ...
Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, will host a conference call and live webcast on Wednesday, November ...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis ...